Quest Diagnostics Posts 3Q EPS of $2.78
DGX sits 37% above its 52-week low of $171.175.
Summary
Quest Diagnostics reported third-quarter EPS of $2.78 in a Dow Jones Newswires flash, with adjusted EPS of $3.00 and net income of $312 million. The company sees full-year adjusted EPS of $11.25 to $11.35, and full-year EPS of $10.21 to $10.31. Q2 revenue was $3.04 billion, up 10.2% year over year, so volume trends into Q3 are the key read-through once the full release lands.
At the time of this announcement, DGX was trading at $234.99 on NYSE in the Life Sciences sector, with a market capitalization of approximately $26.4B. The 52-week trading range was $171.18 to $248.84. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.